We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$440M
1-Year Est. Return
109.12%
This Fund
S&P 500
This Quarter
Est. Return
+0.59%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$266M
AUM Growth
+$34.2M
(+15%)
Cap. Flow
+$29.8M
Cap. Flow
% of AUM
11.22%
Top 10 Holdings %
Top 10 Hldgs %
46.64%
Holding
94
New
15
Increased
28
Reduced
14
Closed
6
Top Buys
| 1 |
ELOX
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
|
+$3.95M |
| 2 |
GNCA
Genocea Biosciences, Inc.
GNCA
|
+$2.53M |
| 3 |
AUTL
Autolus Therapeutics
AUTL
|
+$2.24M |
| 4 |
EPZM
Epizyme, Inc
EPZM
|
+$2.23M |
| 5 |
GMDA
Gamida Cell Ltd. Ordinary Shares
GMDA
|
+$2.16M |
Top Sells
| 1 |
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
|
+$1.59M |
| 2 |
ADXS
Advaxis Inc
ADXS
|
+$1.2M |
| 3 |
Arbutus Biopharma
ABUS
|
+$884K |
| 4 |
Savara
SVRA
|
+$813K |
| 5 |
MRSN
Mersana Therapeutics
MRSN
|
+$603K |
Sector Composition
| 1 | Healthcare | 91.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Stereotaxis
STXS
$161M
| $39.7M | 14.91% |
13,680,554
| – | – |
|
|
SAGE
2
DELISTED
Sage Therapeutics
SAGE
| $22.7M | 8.52% |
123,806
| – | – |
|
|
BPMC
3
DELISTED
Blueprint Medicines
BPMC
| $11.6M | 4.37% |
123,218
+3,500
| +3% | +$289K |
|
4
AtriCure
ATRC
$1.75B
| $9.51M | 3.58% |
318,729
| – | – |
|
|
ALDR
5
DELISTED
Alder Biopharmaceuticals
ALDR
| $7.49M | 2.81% |
636,013
+65,000
| +11% | +$787K |
|
6
Ascendis Pharma A/S
ASND
$17.6B
| $6.84M | 2.57% |
59,380
+15,000
| +34% | +$1.79M |
|
|
LKFT
7
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
| $6.77M | 2.54% |
52,509
+2,900
| +6% | +$344K |
|
|
ZGNX
8
DELISTED
Zogenix, Inc.
ZGNX
| $6.73M | 2.53% |
140,764
+11,000
| +8% | +$443K |
|
9
iShares Biotechnology ETF
IBB
$9.24B
| $6.7M | 2.52% |
61,400
| – | – |
|
|
AERI
10
DELISTED
Aerie Pharmaceuticals
AERI
| $6.07M | 2.28% |
205,440
+53,670
| +35% | +$2.07M |
|
11
Wave Life Sciences
WVE
$1.14B
| $5.68M | 2.13% |
217,554
+27,000
| +14% | +$757K |
|
|
ARNA
12
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.51M | 2.07% |
93,942
| – | – |
|
|
ARQL
13
DELISTED
Arqule Inc
ARQL
| $5.48M | 2.06% |
497,762
+124,598
| +33% | +$867K |
|
14
Neurocrine Biosciences
NBIX
$17.3B
| $5.46M | 2.05% |
64,608
+9,600
| +17% | +$788K |
|
15
DexCom
DXCM
$28.1B
| $5.45M | 2.05% |
145,352
+16,000
| +12% | +$503K |
|
16
Cytokinetics
CYTK
$11.2B
| $5.37M | 2.02% |
477,196
+76,902
| +19% | +$742K |
|
17
argenx
ARGX
$54B
| $4.5M | 1.69% |
31,750
-3,900
| -11% | -$495K |
|
|
TVRD
18
Tvardi Therapeutics
TVRD
$27.5M
| $4.41M | 1.66% |
5,695
+1,706
| +43% | +$1.2M |
|
|
BHVN
19
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $4.16M | 1.56% |
95,000
+15,000
| +19% | +$846K |
|
20
Akebia Therapeutics
AKBA
$370M
| $4.02M | 1.51% |
830,538
+115,000
| +16% | +$654K |
|
|
LMNX
21
DELISTED
Luminex Corp
LMNX
| $4.01M | 1.51% |
194,091
+55,700
| +40% | +$1.22M |
|
|
ELOX
22
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
| $3.74M | 1.41% |
+9,375
| New | +$3.95M |
|
23
VYNE Therapeutics
VYNE
$25.3M
| $3.59M | 1.35% |
8,334
| – | – |
|
24
Xenon Pharmaceuticals
XENE
$6.55B
| $3.26M | 1.23% |
330,667
| – | – |
|
|
BLUE
25
DELISTED
bluebird bio
BLUE
| $3.24M | 1.22% |
1,969
-115
| -6% | -$199K |
|
Similar funds
FGWP
STCG
SCP
CAAM
AWM
HCM
CPW
DWML